Anandamide-d8 is a deuterated labeled version of Anandamide, an endocannabinoid that plays a role in modulating both neuronal and immune functions through CB1 and CB2 cannabinoid receptors. It can also activate other receptors such as PPARS, TRPV1, GPR18, and GPR55. Anandamide exhibits potential anti-fungal and anti-inflammatory activities and is being researched for its use in Alzheimer's disease (AD) and ulcerative colitis.
- Deuterated labeled Anandamide.
- Modulates neuronal and immune functions via CB1 and CB2 receptors.
- Activates receptors including PPARS, TRPV1, GPR18, and GPR55.
- Possesses potential anti-fungal and anti-inflammatory properties.
- Applicable for research in Alzheimer's disease (AD) and ulcerative colitis.
- Can be utilized as a tracer.
- Suitable for use as an internal standard for quantitative analysis by methods such as NMR, GC-MS, or LC-MS.